What do we know about Immunity to SARS-CoV-2? Implications for Public Health Policies

Autor/a

Blanco Arbués, Julià

Sarukhan, Adelaida

Díez Antón, Juana, 1962-

Bassat Orellana, Quique

Campins Martí, Magda

Güerri Fernández, Robert

Brotons, Carlos

Sans Corrales, Mireia

Miró Meda, José M. (José María), 1956-

Sanjosé Llongueras, Silvia de

Data de publicació

2021-02-24T11:30:18Z

2021-02-24T11:30:18Z

2021-02-24

Resum

Additional support from ISGlobal’s Antoni Plasència and Josep M. Antó


As the COVID-19 pandemic progresses, so does our knowledge of the magnitude, type and durability of the immune response to SARS-CoV-2 as a result of natural infection or vaccination. This information is crucial since it will largely define the strategies we need to implement in order to protect individuals and populations. With this in mind, the GCMSC presents its second report, where they review the current knowledge on immunity to SARS-CoV-2 and the implications in terms of public health policies.

Tipus de document

Informe

Llengua

Anglès

Matèries i paraules clau

COVID-19; Vacunes; Immunitat; Salut pública; COVID-19; Vaccines; Immunity; Public health

Publicat per

Institut de Salut Global de Barcelona (ISGlobal)

Col·legi Oficial de Metges de Barcelona (COMB)

Drets

cc-by (c) Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC), 2021

http://creativecommons.org/licenses/by/3.0/es/

Aquest element apareix en la col·lecció o col·leccions següent(s)